PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 176 filers reported holding PRECIGEN INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,828 | +23.5% | 3,400 | 0.0% | 0.00% | – |
| Q2 2023 | $3,910 | +4.4% | 3,400 | -3.7% | 0.00% | – |
| Q1 2023 | $3,744 | -30.3% | 3,532 | 0.0% | 0.00% | – |
| Q4 2022 | $5,369 | -40.3% | 3,532 | -16.3% | 0.00% | – |
| Q3 2022 | $9,000 | +50.0% | 4,222 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | -40.0% | 4,222 | -14.2% | 0.00% | – |
| Q1 2022 | $10,000 | -44.4% | 4,922 | 0.0% | 0.00% | – |
| Q4 2021 | $18,000 | -37.9% | 4,922 | -15.5% | 0.00% | – |
| Q3 2021 | $29,000 | -34.1% | 5,822 | -13.4% | 0.00% | -100.0% |
| Q2 2021 | $44,000 | -100.0% | 6,722 | -50.0% | 0.00% | 0.0% |
| Q1 2021 | $92,630,000 | +125075.7% | 13,444 | +86.2% | 0.00% | -50.0% |
| Q4 2020 | $74,000 | +252.4% | 7,222 | +22.0% | 0.00% | +100.0% |
| Q3 2020 | $21,000 | -30.0% | 5,922 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $30,000 | +50.0% | 5,922 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $20,000 | – | 5,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |